Presentation TCT 2013 TCT-13. Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents Presenter: Peter Smits October 29, 2013
Presentation TCT 2013 Case Presentation and Topic Review: Approaches to NSVT After Alcohol Septal Ablation Presenter: Michael Fifer October 29, 2013
Presentation TCT 2013 TCT-51. Prognostic impact of chronic total occlusion in patients with different severity of coronary artery disease - A report from the Swedish Coronary Angiography and... Presenter: Truls R?munddal October 29, 2013
Presentation TCT 2013 Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 4-Year Results from the BioFreedom First-In-Man Trial Presenter: 208788|Ricardo Costa October 29, 2013
Presentation TCT 2013 Non-cellular Therapies in the Clinic: SDF-1 and Other Agents Presenter: Marc Penn October 29, 2013
Presentation TCT 2013 Update on ADSCs and MPCs for STEMI Presenter: Henricus Duckers October 29, 2013
Presentation TCT 2013 Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO Presenter: Timothy Henry October 29, 2013
Presentation TCT 2013 Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study Presenter: Shao-?Liang Chen October 29, 2013
Presentation TCT 2013 TCT-80. Applicability of hybrid strategy (resting index plus selective FFR) to assess hemodynamic significance of coronary stenoses depends on FFR distribution Presenter: Nils Johnson October 29, 2013